English | Español
English | Español
  • Insurance
  • Marketing
  • Pharmaceuticals
  • Technology/Innovation
  • Regulatory
  • Community

American Academy Of Neurology

Sam Jackson | Apr 25, 2023

Teriflunomide study shows promise in delaying first symptoms of MS using medication as an 'early intervention'

Sam Jackson | Apr 25, 2023

New drug shows promise in preventing migraines for patients unresponsive to other treatments: 'These results are exciting'

Press release submission | May 2, 2019

AMERICAN ACADEMY OF NEUROLOGY: Cannabis-based Medicine May Reduce Seizures for Children with Difficult-to-Treat Epilepsy

Robert Hadley | May 16, 2017

Immunosuppressive drug cladribine may slow progression of MS

Ruth de Jauregui | May 7, 2017

Data from multiple sclerosis medication study shows promise

Robert Hadley | May 3, 2017

Clinical trial results offer hope for multiple sclerosis sufferers

Amanda Rupp | May 22, 2016

New ALS research announced at annual conference

Amanda Rupp | Apr 21, 2016

ALS Association announces new research fellowships

Trending

Patient Daily | Oct 9, 2025

Medfluence Advisors Marketing Expert: 'The conversations leading into AAO-HNSF are shaping how ENT practices approach growth and engagement'

+ Technology/Innovation
Patient Daily News Service | Oct 9, 2025

Babylon Health collapse raises questions about AI claims across industries

Patient Daily | Oct 9, 2025

AI takes center stage at ASCENT ENT conference, reshaping marketing and operations

+ Regulatory
Patient Daily | Oct 14, 2025

Mackinac Center raises concerns over federal 340B drug pricing program’s market impact



Community
Insurance
Marketing
Pharmaceuticals
Regulatory
Technology/Innovation
About
Contact
© 2025 Patient Daily